| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Expected but not Quantified |
|---|
| Creation Date | 2012-09-06 15:00:12 UTC |
|---|
| Update Date | 2021-09-14 15:45:05 UTC |
|---|
| HMDB ID | HMDB0013847 |
|---|
| Secondary Accession Numbers | |
|---|
| Metabolite Identification |
|---|
| Common Name | Losartan N2-glucuronide |
|---|
| Description | Losartan N2-glucuronide belongs to the class of organic compounds known as glucuronic acid derivatives. Glucuronic acid derivatives are compounds containing a glucuronic acid moiety (or a derivative), which consists of a glucose moiety with the C6 carbon oxidized to a carboxylic acid. Losartan N2-glucuronide is a strong basic compound (based on its pKa). |
|---|
| Structure | CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=C1)C1=CC=CC=C1C1=NN(N=N1)[C@@H]1O[C@@H]([C@@H](O)[C@H](O)[C@H]1O)C(O)=O InChI=1S/C28H31ClN6O7/c1-2-3-8-20-30-25(29)19(14-36)34(20)13-15-9-11-16(12-10-15)17-6-4-5-7-18(17)26-31-33-35(32-26)27-23(39)21(37)22(38)24(42-27)28(40)41/h4-7,9-12,21-24,27,36-39H,2-3,8,13-14H2,1H3,(H,40,41)/t21-,22-,23+,24-,27+/m0/s1 |
|---|
| Synonyms | | Value | Source |
|---|
| (2S,3S,4S,5R,6R)-6-[5-(4'-{[2-butyl-4-chloro-5-(hydroxymethyl)-1H-imidazol-1-yl]methyl}-[1,1'-biphenyl]-2-yl)-2H-1,2,3,4-tetrazol-2-yl]-3,4,5-trihydroxyoxane-2-carboxylate | Generator |
|
|---|
| Chemical Formula | C28H31ClN6O7 |
|---|
| Average Molecular Weight | 599.035 |
|---|
| Monoisotopic Molecular Weight | 598.194275083 |
|---|
| IUPAC Name | (2S,3S,4S,5R,6R)-6-{5-[2-(4-{[2-butyl-4-chloro-5-(hydroxymethyl)-1H-imidazol-1-yl]methyl}phenyl)phenyl]-2H-1,2,3,4-tetrazol-2-yl}-3,4,5-trihydroxyoxane-2-carboxylic acid |
|---|
| Traditional Name | (2S,3S,4S,5R,6R)-6-{5-[2-(4-{[2-butyl-4-chloro-5-(hydroxymethyl)imidazol-1-yl]methyl}phenyl)phenyl]-1,2,3,4-tetrazol-2-yl}-3,4,5-trihydroxyoxane-2-carboxylic acid |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=C1)C1=CC=CC=C1C1=NN(N=N1)[C@@H]1O[C@@H]([C@@H](O)[C@H](O)[C@H]1O)C(O)=O |
|---|
| InChI Identifier | InChI=1S/C28H31ClN6O7/c1-2-3-8-20-30-25(29)19(14-36)34(20)13-15-9-11-16(12-10-15)17-6-4-5-7-18(17)26-31-33-35(32-26)27-23(39)21(37)22(38)24(42-27)28(40)41/h4-7,9-12,21-24,27,36-39H,2-3,8,13-14H2,1H3,(H,40,41)/t21-,22-,23+,24-,27+/m0/s1 |
|---|
| InChI Key | NGFMQMUIOUSHGR-RTCYWULBSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as glucuronic acid derivatives. Glucuronic acid derivatives are compounds containing a glucuronic acid moiety (or a derivative), which consists of a glucose moiety with the C6 carbon oxidized to a carboxylic acid. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organic oxygen compounds |
|---|
| Class | Organooxygen compounds |
|---|
| Sub Class | Carbohydrates and carbohydrate conjugates |
|---|
| Direct Parent | Glucuronic acid derivatives |
|---|
| Alternative Parents | |
|---|
| Substituents | - Glucuronic acid or derivatives
- Biphenyl
- Phenyltetrazole
- 1,2,4,5-tetrasubstituted imidazole
- Imidazolyl carboxylic acid derivative
- Beta-hydroxy acid
- Hydroxy acid
- Benzenoid
- Monocyclic benzene moiety
- Pyran
- N-substituted imidazole
- Aryl halide
- Oxane
- Aryl chloride
- Azole
- Imidazole
- Tetrazole
- Heteroaromatic compound
- Secondary alcohol
- Carboxylic acid
- Carboxylic acid derivative
- Monocarboxylic acid or derivatives
- Polyol
- Organoheterocyclic compound
- Azacycle
- Oxacycle
- Organic nitrogen compound
- Organohalogen compound
- Organochloride
- Carbonyl group
- Organonitrogen compound
- Primary alcohol
- Aromatic alcohol
- Hydrocarbon derivative
- Organic oxide
- Organopnictogen compound
- Alcohol
- Aromatic heteromonocyclic compound
|
|---|
| Molecular Framework | Aromatic heteromonocyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | Not Available |
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Solid |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 5.25 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 15.9085 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 3.5 minutes | 32390414 | | AjsUoB = Accucore 150 Amide HILIC with 10mM Ammonium Formate, 0.1% Formic Acid | 60.1 seconds | 40023050 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 3007.8 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 241.0 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 223.4 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 189.3 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 193.9 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 583.4 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 578.2 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 108.8 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 1318.3 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 658.9 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 1848.5 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 432.8 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 452.6 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 259.0 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 139.0 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 85.2 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| Losartan N2-glucuronide,1TMS,isomer #1 | CCCCC1=NC(Cl)=C(CO[Si](C)(C)C)N1CC1=CC=C(C2=CC=CC=C2C2=NN([C@@H]3O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]3O)N=N2)C=C1 | 4922.9 | Semi standard non polar | 33892256 | | Losartan N2-glucuronide,1TMS,isomer #2 | CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C2=CC=CC=C2C2=NN([C@@H]3O[C@H](C(=O)O)[C@@H](O[Si](C)(C)C)[C@H](O)[C@H]3O)N=N2)C=C1 | 4922.5 | Semi standard non polar | 33892256 | | Losartan N2-glucuronide,1TMS,isomer #3 | CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C2=CC=CC=C2C2=NN([C@@H]3O[C@H](C(=O)O)[C@@H](O)[C@H](O[Si](C)(C)C)[C@H]3O)N=N2)C=C1 | 4919.7 | Semi standard non polar | 33892256 | | Losartan N2-glucuronide,1TMS,isomer #4 | CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C2=CC=CC=C2C2=NN([C@@H]3O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]3O[Si](C)(C)C)N=N2)C=C1 | 4924.5 | Semi standard non polar | 33892256 | | Losartan N2-glucuronide,1TMS,isomer #5 | CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C2=CC=CC=C2C2=NN([C@@H]3O[C@H](C(=O)O[Si](C)(C)C)[C@@H](O)[C@H](O)[C@H]3O)N=N2)C=C1 | 4861.1 | Semi standard non polar | 33892256 | | Losartan N2-glucuronide,2TMS,isomer #1 | CCCCC1=NC(Cl)=C(CO[Si](C)(C)C)N1CC1=CC=C(C2=CC=CC=C2C2=NN([C@@H]3O[C@H](C(=O)O[Si](C)(C)C)[C@@H](O)[C@H](O)[C@H]3O)N=N2)C=C1 | 4807.0 | Semi standard non polar | 33892256 | | Losartan N2-glucuronide,2TMS,isomer #10 | CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C2=CC=CC=C2C2=NN([C@@H]3O[C@H](C(=O)O[Si](C)(C)C)[C@@H](O)[C@H](O)[C@H]3O[Si](C)(C)C)N=N2)C=C1 | 4798.8 | Semi standard non polar | 33892256 | | Losartan N2-glucuronide,2TMS,isomer #2 | CCCCC1=NC(Cl)=C(CO[Si](C)(C)C)N1CC1=CC=C(C2=CC=CC=C2C2=NN([C@@H]3O[C@H](C(=O)O)[C@@H](O[Si](C)(C)C)[C@H](O)[C@H]3O)N=N2)C=C1 | 4832.4 | Semi standard non polar | 33892256 | | Losartan N2-glucuronide,2TMS,isomer #3 | CCCCC1=NC(Cl)=C(CO[Si](C)(C)C)N1CC1=CC=C(C2=CC=CC=C2C2=NN([C@@H]3O[C@H](C(=O)O)[C@@H](O)[C@H](O[Si](C)(C)C)[C@H]3O)N=N2)C=C1 | 4837.6 | Semi standard non polar | 33892256 | | Losartan N2-glucuronide,2TMS,isomer #4 | CCCCC1=NC(Cl)=C(CO[Si](C)(C)C)N1CC1=CC=C(C2=CC=CC=C2C2=NN([C@@H]3O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]3O[Si](C)(C)C)N=N2)C=C1 | 4839.0 | Semi standard non polar | 33892256 | | Losartan N2-glucuronide,2TMS,isomer #5 | CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C2=CC=CC=C2C2=NN([C@@H]3O[C@H](C(=O)O[Si](C)(C)C)[C@@H](O[Si](C)(C)C)[C@H](O)[C@H]3O)N=N2)C=C1 | 4808.8 | Semi standard non polar | 33892256 | | Losartan N2-glucuronide,2TMS,isomer #6 | CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C2=CC=CC=C2C2=NN([C@@H]3O[C@H](C(=O)O)[C@@H](O[Si](C)(C)C)[C@H](O[Si](C)(C)C)[C@H]3O)N=N2)C=C1 | 4843.0 | Semi standard non polar | 33892256 | | Losartan N2-glucuronide,2TMS,isomer #7 | CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C2=CC=CC=C2C2=NN([C@@H]3O[C@H](C(=O)O)[C@@H](O[Si](C)(C)C)[C@H](O)[C@H]3O[Si](C)(C)C)N=N2)C=C1 | 4838.2 | Semi standard non polar | 33892256 | | Losartan N2-glucuronide,2TMS,isomer #8 | CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C2=CC=CC=C2C2=NN([C@@H]3O[C@H](C(=O)O[Si](C)(C)C)[C@@H](O)[C@H](O[Si](C)(C)C)[C@H]3O)N=N2)C=C1 | 4798.8 | Semi standard non polar | 33892256 | | Losartan N2-glucuronide,2TMS,isomer #9 | CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C2=CC=CC=C2C2=NN([C@@H]3O[C@H](C(=O)O)[C@@H](O)[C@H](O[Si](C)(C)C)[C@H]3O[Si](C)(C)C)N=N2)C=C1 | 4840.9 | Semi standard non polar | 33892256 | | Losartan N2-glucuronide,3TMS,isomer #1 | CCCCC1=NC(Cl)=C(CO[Si](C)(C)C)N1CC1=CC=C(C2=CC=CC=C2C2=NN([C@@H]3O[C@H](C(=O)O[Si](C)(C)C)[C@@H](O[Si](C)(C)C)[C@H](O)[C@H]3O)N=N2)C=C1 | 4788.7 | Semi standard non polar | 33892256 | | Losartan N2-glucuronide,3TMS,isomer #10 | CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C2=CC=CC=C2C2=NN([C@@H]3O[C@H](C(=O)O[Si](C)(C)C)[C@@H](O)[C@H](O[Si](C)(C)C)[C@H]3O[Si](C)(C)C)N=N2)C=C1 | 4799.8 | Semi standard non polar | 33892256 | | Losartan N2-glucuronide,3TMS,isomer #2 | CCCCC1=NC(Cl)=C(CO[Si](C)(C)C)N1CC1=CC=C(C2=CC=CC=C2C2=NN([C@@H]3O[C@H](C(=O)O[Si](C)(C)C)[C@@H](O)[C@H](O[Si](C)(C)C)[C@H]3O)N=N2)C=C1 | 4783.6 | Semi standard non polar | 33892256 | | Losartan N2-glucuronide,3TMS,isomer #3 | CCCCC1=NC(Cl)=C(CO[Si](C)(C)C)N1CC1=CC=C(C2=CC=CC=C2C2=NN([C@@H]3O[C@H](C(=O)O[Si](C)(C)C)[C@@H](O)[C@H](O)[C@H]3O[Si](C)(C)C)N=N2)C=C1 | 4782.8 | Semi standard non polar | 33892256 | | Losartan N2-glucuronide,3TMS,isomer #4 | CCCCC1=NC(Cl)=C(CO[Si](C)(C)C)N1CC1=CC=C(C2=CC=CC=C2C2=NN([C@@H]3O[C@H](C(=O)O)[C@@H](O[Si](C)(C)C)[C@H](O[Si](C)(C)C)[C@H]3O)N=N2)C=C1 | 4814.5 | Semi standard non polar | 33892256 | | Losartan N2-glucuronide,3TMS,isomer #5 | CCCCC1=NC(Cl)=C(CO[Si](C)(C)C)N1CC1=CC=C(C2=CC=CC=C2C2=NN([C@@H]3O[C@H](C(=O)O)[C@@H](O[Si](C)(C)C)[C@H](O)[C@H]3O[Si](C)(C)C)N=N2)C=C1 | 4811.3 | Semi standard non polar | 33892256 | | Losartan N2-glucuronide,3TMS,isomer #6 | CCCCC1=NC(Cl)=C(CO[Si](C)(C)C)N1CC1=CC=C(C2=CC=CC=C2C2=NN([C@@H]3O[C@H](C(=O)O)[C@@H](O)[C@H](O[Si](C)(C)C)[C@H]3O[Si](C)(C)C)N=N2)C=C1 | 4808.4 | Semi standard non polar | 33892256 | | Losartan N2-glucuronide,3TMS,isomer #7 | CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C2=CC=CC=C2C2=NN([C@@H]3O[C@H](C(=O)O[Si](C)(C)C)[C@@H](O[Si](C)(C)C)[C@H](O[Si](C)(C)C)[C@H]3O)N=N2)C=C1 | 4803.3 | Semi standard non polar | 33892256 | | Losartan N2-glucuronide,3TMS,isomer #8 | CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C2=CC=CC=C2C2=NN([C@@H]3O[C@H](C(=O)O[Si](C)(C)C)[C@@H](O[Si](C)(C)C)[C@H](O)[C@H]3O[Si](C)(C)C)N=N2)C=C1 | 4799.8 | Semi standard non polar | 33892256 | | Losartan N2-glucuronide,3TMS,isomer #9 | CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C2=CC=CC=C2C2=NN([C@@H]3O[C@H](C(=O)O)[C@@H](O[Si](C)(C)C)[C@H](O[Si](C)(C)C)[C@H]3O[Si](C)(C)C)N=N2)C=C1 | 4840.9 | Semi standard non polar | 33892256 | | Losartan N2-glucuronide,4TMS,isomer #1 | CCCCC1=NC(Cl)=C(CO[Si](C)(C)C)N1CC1=CC=C(C2=CC=CC=C2C2=NN([C@@H]3O[C@H](C(=O)O[Si](C)(C)C)[C@@H](O[Si](C)(C)C)[C@H](O[Si](C)(C)C)[C@H]3O)N=N2)C=C1 | 4787.2 | Semi standard non polar | 33892256 | | Losartan N2-glucuronide,4TMS,isomer #2 | CCCCC1=NC(Cl)=C(CO[Si](C)(C)C)N1CC1=CC=C(C2=CC=CC=C2C2=NN([C@@H]3O[C@H](C(=O)O[Si](C)(C)C)[C@@H](O[Si](C)(C)C)[C@H](O)[C@H]3O[Si](C)(C)C)N=N2)C=C1 | 4784.0 | Semi standard non polar | 33892256 | | Losartan N2-glucuronide,4TMS,isomer #3 | CCCCC1=NC(Cl)=C(CO[Si](C)(C)C)N1CC1=CC=C(C2=CC=CC=C2C2=NN([C@@H]3O[C@H](C(=O)O[Si](C)(C)C)[C@@H](O)[C@H](O[Si](C)(C)C)[C@H]3O[Si](C)(C)C)N=N2)C=C1 | 4779.7 | Semi standard non polar | 33892256 | | Losartan N2-glucuronide,4TMS,isomer #4 | CCCCC1=NC(Cl)=C(CO[Si](C)(C)C)N1CC1=CC=C(C2=CC=CC=C2C2=NN([C@@H]3O[C@H](C(=O)O)[C@@H](O[Si](C)(C)C)[C@H](O[Si](C)(C)C)[C@H]3O[Si](C)(C)C)N=N2)C=C1 | 4815.1 | Semi standard non polar | 33892256 | | Losartan N2-glucuronide,4TMS,isomer #5 | CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C2=CC=CC=C2C2=NN([C@@H]3O[C@H](C(=O)O[Si](C)(C)C)[C@@H](O[Si](C)(C)C)[C@H](O[Si](C)(C)C)[C@H]3O[Si](C)(C)C)N=N2)C=C1 | 4810.3 | Semi standard non polar | 33892256 | | Losartan N2-glucuronide,1TBDMS,isomer #1 | CCCCC1=NC(Cl)=C(CO[Si](C)(C)C(C)(C)C)N1CC1=CC=C(C2=CC=CC=C2C2=NN([C@@H]3O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]3O)N=N2)C=C1 | 5090.1 | Semi standard non polar | 33892256 | | Losartan N2-glucuronide,1TBDMS,isomer #2 | CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C2=CC=CC=C2C2=NN([C@@H]3O[C@H](C(=O)O)[C@@H](O[Si](C)(C)C(C)(C)C)[C@H](O)[C@H]3O)N=N2)C=C1 | 5064.8 | Semi standard non polar | 33892256 | | Losartan N2-glucuronide,1TBDMS,isomer #3 | CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C2=CC=CC=C2C2=NN([C@@H]3O[C@H](C(=O)O)[C@@H](O)[C@H](O[Si](C)(C)C(C)(C)C)[C@H]3O)N=N2)C=C1 | 5075.0 | Semi standard non polar | 33892256 | | Losartan N2-glucuronide,1TBDMS,isomer #4 | CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C2=CC=CC=C2C2=NN([C@@H]3O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]3O[Si](C)(C)C(C)(C)C)N=N2)C=C1 | 5083.6 | Semi standard non polar | 33892256 | | Losartan N2-glucuronide,1TBDMS,isomer #5 | CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C2=CC=CC=C2C2=NN([C@@H]3O[C@H](C(=O)O[Si](C)(C)C(C)(C)C)[C@@H](O)[C@H](O)[C@H]3O)N=N2)C=C1 | 5055.4 | Semi standard non polar | 33892256 | | Losartan N2-glucuronide,2TBDMS,isomer #1 | CCCCC1=NC(Cl)=C(CO[Si](C)(C)C(C)(C)C)N1CC1=CC=C(C2=CC=CC=C2C2=NN([C@@H]3O[C@H](C(=O)O[Si](C)(C)C(C)(C)C)[C@@H](O)[C@H](O)[C@H]3O)N=N2)C=C1 | 5134.5 | Semi standard non polar | 33892256 | | Losartan N2-glucuronide,2TBDMS,isomer #10 | CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C2=CC=CC=C2C2=NN([C@@H]3O[C@H](C(=O)O[Si](C)(C)C(C)(C)C)[C@@H](O)[C@H](O)[C@H]3O[Si](C)(C)C(C)(C)C)N=N2)C=C1 | 5131.1 | Semi standard non polar | 33892256 | | Losartan N2-glucuronide,2TBDMS,isomer #2 | CCCCC1=NC(Cl)=C(CO[Si](C)(C)C(C)(C)C)N1CC1=CC=C(C2=CC=CC=C2C2=NN([C@@H]3O[C@H](C(=O)O)[C@@H](O[Si](C)(C)C(C)(C)C)[C@H](O)[C@H]3O)N=N2)C=C1 | 5133.3 | Semi standard non polar | 33892256 | | Losartan N2-glucuronide,2TBDMS,isomer #3 | CCCCC1=NC(Cl)=C(CO[Si](C)(C)C(C)(C)C)N1CC1=CC=C(C2=CC=CC=C2C2=NN([C@@H]3O[C@H](C(=O)O)[C@@H](O)[C@H](O[Si](C)(C)C(C)(C)C)[C@H]3O)N=N2)C=C1 | 5135.9 | Semi standard non polar | 33892256 | | Losartan N2-glucuronide,2TBDMS,isomer #4 | CCCCC1=NC(Cl)=C(CO[Si](C)(C)C(C)(C)C)N1CC1=CC=C(C2=CC=CC=C2C2=NN([C@@H]3O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]3O[Si](C)(C)C(C)(C)C)N=N2)C=C1 | 5146.9 | Semi standard non polar | 33892256 | | Losartan N2-glucuronide,2TBDMS,isomer #5 | CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C2=CC=CC=C2C2=NN([C@@H]3O[C@H](C(=O)O[Si](C)(C)C(C)(C)C)[C@@H](O[Si](C)(C)C(C)(C)C)[C@H](O)[C@H]3O)N=N2)C=C1 | 5131.3 | Semi standard non polar | 33892256 | | Losartan N2-glucuronide,2TBDMS,isomer #6 | CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C2=CC=CC=C2C2=NN([C@@H]3O[C@H](C(=O)O)[C@@H](O[Si](C)(C)C(C)(C)C)[C@H](O[Si](C)(C)C(C)(C)C)[C@H]3O)N=N2)C=C1 | 5124.2 | Semi standard non polar | 33892256 | | Losartan N2-glucuronide,2TBDMS,isomer #7 | CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C2=CC=CC=C2C2=NN([C@@H]3O[C@H](C(=O)O)[C@@H](O[Si](C)(C)C(C)(C)C)[C@H](O)[C@H]3O[Si](C)(C)C(C)(C)C)N=N2)C=C1 | 5125.4 | Semi standard non polar | 33892256 | | Losartan N2-glucuronide,2TBDMS,isomer #8 | CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C2=CC=CC=C2C2=NN([C@@H]3O[C@H](C(=O)O[Si](C)(C)C(C)(C)C)[C@@H](O)[C@H](O[Si](C)(C)C(C)(C)C)[C@H]3O)N=N2)C=C1 | 5127.4 | Semi standard non polar | 33892256 | | Losartan N2-glucuronide,2TBDMS,isomer #9 | CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C2=CC=CC=C2C2=NN([C@@H]3O[C@H](C(=O)O)[C@@H](O)[C@H](O[Si](C)(C)C(C)(C)C)[C@H]3O[Si](C)(C)C(C)(C)C)N=N2)C=C1 | 5131.7 | Semi standard non polar | 33892256 |
|
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted GC-MS | Predicted GC-MS Spectrum - Losartan N2-glucuronide GC-MS (Non-derivatized) - 70eV, Positive | splash10-0019-9300250000-0cbb81ca89cfafd23ac5 | 2017-09-01 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Losartan N2-glucuronide GC-MS (1 TMS) - 70eV, Positive | splash10-001i-5920103000-cdf74b61bfafa699a7a6 | 2017-10-06 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Losartan N2-glucuronide GC-MS (TMS_1_2) - 70eV, Positive | Not Available | 2021-10-16 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Losartan N2-glucuronide GC-MS (TMS_1_3) - 70eV, Positive | Not Available | 2021-10-16 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Losartan N2-glucuronide GC-MS (TMS_1_4) - 70eV, Positive | Not Available | 2021-10-16 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Losartan N2-glucuronide GC-MS (TMS_1_5) - 70eV, Positive | Not Available | 2021-10-16 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Losartan N2-glucuronide GC-MS (TMS_2_1) - 70eV, Positive | Not Available | 2021-10-16 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Losartan N2-glucuronide GC-MS (TMS_2_2) - 70eV, Positive | Not Available | 2021-10-16 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Losartan N2-glucuronide GC-MS (TMS_2_3) - 70eV, Positive | Not Available | 2021-10-16 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Losartan N2-glucuronide GC-MS (TMS_2_4) - 70eV, Positive | Not Available | 2021-10-16 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Losartan N2-glucuronide GC-MS (TMS_2_5) - 70eV, Positive | Not Available | 2021-10-16 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Losartan N2-glucuronide GC-MS (TMS_2_6) - 70eV, Positive | Not Available | 2021-10-16 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Losartan N2-glucuronide GC-MS (TMS_2_7) - 70eV, Positive | Not Available | 2021-10-16 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Losartan N2-glucuronide GC-MS (TMS_2_8) - 70eV, Positive | Not Available | 2021-10-16 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Losartan N2-glucuronide GC-MS (TMS_2_9) - 70eV, Positive | Not Available | 2021-10-16 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Losartan N2-glucuronide GC-MS (TMS_2_10) - 70eV, Positive | Not Available | 2021-10-16 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Losartan N2-glucuronide GC-MS (TMS_3_1) - 70eV, Positive | Not Available | 2021-10-16 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Losartan N2-glucuronide GC-MS (TMS_3_2) - 70eV, Positive | Not Available | 2021-10-16 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Losartan N2-glucuronide GC-MS (TMS_3_3) - 70eV, Positive | Not Available | 2021-10-16 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Losartan N2-glucuronide GC-MS (TMS_3_4) - 70eV, Positive | Not Available | 2021-10-16 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Losartan N2-glucuronide GC-MS (TMS_3_5) - 70eV, Positive | Not Available | 2021-10-16 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Losartan N2-glucuronide GC-MS (TMS_3_6) - 70eV, Positive | Not Available | 2021-10-16 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Losartan N2-glucuronide GC-MS (TMS_3_7) - 70eV, Positive | Not Available | 2021-10-16 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Losartan N2-glucuronide GC-MS (TMS_3_8) - 70eV, Positive | Not Available | 2021-10-16 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Losartan N2-glucuronide GC-MS (TMS_3_9) - 70eV, Positive | Not Available | 2021-10-16 | Wishart Lab | View Spectrum |
MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Losartan N2-glucuronide 10V, Positive-QTOF | splash10-0006-0911240000-e5cfb7a73a176ac26d03 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Losartan N2-glucuronide 20V, Positive-QTOF | splash10-06ur-1416950000-2a5dcadbc0a0d1e69dab | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Losartan N2-glucuronide 40V, Positive-QTOF | splash10-03fr-6719000000-4d3b304fc05a6228f63b | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Losartan N2-glucuronide 10V, Negative-QTOF | splash10-00ds-0202950000-cb387ed6228c02ed3bf3 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Losartan N2-glucuronide 20V, Negative-QTOF | splash10-059i-9501420000-395262ddf4b58d0389ea | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Losartan N2-glucuronide 40V, Negative-QTOF | splash10-052r-9400000000-d0e90776bbf68040f3ae | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Losartan N2-glucuronide 10V, Negative-QTOF | splash10-0002-0000090000-81a9f867ce1ed2865497 | 2021-09-23 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Losartan N2-glucuronide 20V, Negative-QTOF | splash10-0532-3301690000-a014a1869f571deffa74 | 2021-09-23 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Losartan N2-glucuronide 40V, Negative-QTOF | splash10-0uea-1900010000-c803db25c30de3854f5d | 2021-09-23 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Losartan N2-glucuronide 10V, Positive-QTOF | splash10-0002-0000390000-38217695e6230440a669 | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Losartan N2-glucuronide 20V, Positive-QTOF | splash10-06rj-0259870000-3ef687035c8d5d3b431b | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Losartan N2-glucuronide 40V, Positive-QTOF | splash10-000i-0191200000-605f238a7b1705f406cc | 2021-09-24 | Wishart Lab | View Spectrum |
|
|---|